West Pharmaceutical Services Financial Health

Short Term Liabilities: WST's short term assets ($1.7B) exceed its short term liabilities ($456.7M).

Long Term Liabilities: WST's short term assets ($1.7B) exceed its long term liabilities ($389.3M).

Debt Level: WST has more cash than its total debt.

Reducing Debt: WST's debt to equity ratio has reduced from 17.5% to 8.5% over the past 5 years.

Debt Coverage: WST's debt is well covered by operating cash flow (312.3%).

Interest Coverage: WST's interest payments on its debt are well covered by EBIT (117.8x coverage).

• Healthy companies in the Pharmaceuticals & Biotech industry.